“While the majority of the robust, core-lab adjudicated evidence supporting coronary IVL ... patient outcomes. Shockwave has also recently acquired the Neovasc Reducer, which is limited for ...

The Shockwave C2 Coronary IVL device will be eligible for TPT payments for three years. This announcement comes less than two months after CMS recommended Coronary IVL be eligible for incremental ...

Johnson & Johnson (J&J) has agreed to acquire US-based cardiovascular device developer Shockwave Medical in one of the biggest medtech deals in recent years. Confirming rumours that surfaced ...